Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
140.89
-0.08 (-0.06%)
At close: Sep 30, 2026, 4:00 PM EDT
140.71
-0.18 (-0.13%)
After-hours: Sep 30, 2026, 7:30 PM EDT
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $9.12 billion as of September 30, 2026. Its market cap has increased by 124.97% in one year.
Market Cap
9.12B
Enterprise Value
8.28B
1-Year Change
124.97%
Ranking
Category
Stock Price
$140.89
ChartMarket Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $9.12B, an increase of 5,215.89%. That is a compound annual growth rate of 47.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 9.12B | 66.97% |
| Dec 31, 2025 | 5.46B | 137.34% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
| Aug 11, 2016 | 171.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 10.16B |
| Krystal Biotech | 9.98B |
| Kymera Therapeutics | 9.31B |
| Arrowhead Pharmaceuticals | 9.25B |
| Cytokinetics | 9.20B |
| ImmunityBio | 9.03B |
| Caris Life Sciences | 8.97B |
| Vaxcyte | 8.67B |